pd 128042 has been researched along with Hepatocellular Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azuma, Y; Kawasaki, T; Nobuhara, Y; Ohno, K; Seto, J; Yamada, T; Yamasaki, M | 1 |
1 other study(ies) available for pd 128042 and Hepatocellular Carcinoma
Article | Year |
---|---|
Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and secretions of apolipoprotein B-containing lipoprotein and bile acids in HepG2.
Topics: Acetates; Anilides; Aniline Compounds; Apolipoproteins B; Bile Acids and Salts; Carcinoma, Hepatocellular; Cholesterol; Cyclohexanes; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxycholesterols; Lipoproteins; Oleic Acid; Phenylurea Compounds; Phospholipids; Sterol O-Acyltransferase; Triglycerides; Tumor Cells, Cultured | 1999 |